Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
暂无分享,去创建一个
B. Zinman | C. Wanner | D. Fitchett | J. Lachin | S. Inzucchi | U. Broedl | H. Woerle | A. Salsali | O. Johansen | S. Hantel